छोड़कर सामग्री पर जाएँ

Glenmark Pharma Q3 PAT rises 21.3% to Rs 290.8 crore

Consolidated revenue was at Rs 3,463.9 crore, as against Rs 3,173.4 crore, up 9.2 per cent, Glenmark Pharmaceuticals said.

Read More

​ Consolidated revenue was at Rs 3,463.9 crore, as against Rs 3,173.4 crore, up 9.2 per cent, Glenmark Pharmaceuticals said. Consolidated revenue was at Rs 3,463.9 crore, as against Rs 3,173.4 crore, up 9.2 per cent, Glenmark Pharmaceuticals said.  Moneycontrol Latest News Read More  

Top 100 Best Sellers

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी
en_USEnglish hi_INहिन्दी